Eli Lilly stock inches higher as the company joins the coveted trillion-dollar club. Citi analysts believe LLY shares will ...

Eli Lilly on Friday became the first health care company to top $1 trillion in market capitalization, joining a club of ...

Healthcare stocks have outperformed the broader market by nearly 10 percentage points this month as AI bubble concerns have weighed on tech stocks.

Orforglipron is Lilly’s oral GLP-1 in phase 3 development as a treatment for diabetes and obesity. The FDA is expected to approve the drug in March 2026. Lilly’s November news release states that the ...

Several of the environmental advocates and vaccine skeptics who helped propel Kennedy into politics have become impatient ...

The direct-to-employer (DTE) is an industry first for FDA-approved weight-loss drugs like Novo Nordisk's Wegovy (semaglutide) ...

The pharmaceutical giant Novo Nordisk, once a high-flying market darling, is implementing a dramatic strategic pivot. Facing intense competitive pressure fro ...

In summary, under the Trump plan, the U.S. health system continues to fail Americans — by not viewing obesity as a disease, ...